| 4.3 |
13.0 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 4.3 |
21.6 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 3.8 |
11.5 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 3.6 |
10.8 |
GO:2000852 |
regulation of corticosterone secretion(GO:2000852) |
| 3.5 |
3.5 |
GO:0035793 |
cell migration involved in metanephros development(GO:0035788) metanephric mesenchymal cell migration(GO:0035789) positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) regulation of metanephric mesenchymal cell migration(GO:2000589) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
| 3.2 |
9.6 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) |
| 3.2 |
3.2 |
GO:0035934 |
corticosterone secretion(GO:0035934) |
| 3.1 |
12.4 |
GO:1903802 |
L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
| 3.1 |
9.2 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 3.0 |
9.0 |
GO:2001139 |
negative regulation of postsynaptic membrane organization(GO:1901627) negative regulation of dendritic spine maintenance(GO:1902951) negative regulation of phospholipid efflux(GO:1902999) regulation of lipid transport across blood brain barrier(GO:1903000) negative regulation of lipid transport across blood brain barrier(GO:1903001) positive regulation of lipid transport across blood brain barrier(GO:1903002) negative regulation of phospholipid transport(GO:2001139) |
| 3.0 |
11.9 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 2.9 |
14.5 |
GO:1900085 |
negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) |
| 2.8 |
8.5 |
GO:0032513 |
negative regulation of protein phosphatase type 2B activity(GO:0032513) |
| 2.8 |
8.5 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) |
| 2.8 |
2.8 |
GO:0032411 |
positive regulation of transporter activity(GO:0032411) |
| 2.8 |
5.5 |
GO:0032423 |
regulation of mismatch repair(GO:0032423) |
| 2.8 |
11.0 |
GO:0071692 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 2.7 |
8.2 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 2.7 |
10.9 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 2.7 |
2.7 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 2.7 |
16.0 |
GO:1902998 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of tau-protein kinase activity(GO:1902949) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 2.7 |
8.0 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 2.7 |
2.7 |
GO:0060065 |
uterus development(GO:0060065) |
| 2.6 |
10.6 |
GO:0021812 |
neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 2.6 |
7.9 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 2.6 |
10.4 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 2.6 |
23.4 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 2.6 |
2.6 |
GO:1990379 |
lipid transport across blood brain barrier(GO:1990379) |
| 2.6 |
13.0 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 2.6 |
2.6 |
GO:0072103 |
glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 2.6 |
5.2 |
GO:0034372 |
very-low-density lipoprotein particle remodeling(GO:0034372) |
| 2.5 |
2.5 |
GO:0071347 |
cellular response to interleukin-1(GO:0071347) |
| 2.5 |
7.6 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 2.5 |
7.4 |
GO:0042323 |
negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 2.5 |
2.5 |
GO:1903598 |
positive regulation of gap junction assembly(GO:1903598) |
| 2.4 |
9.8 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 2.4 |
14.7 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 2.4 |
2.4 |
GO:0072048 |
pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
| 2.4 |
12.1 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 2.4 |
24.2 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 2.4 |
7.1 |
GO:0070366 |
regulation of hepatocyte differentiation(GO:0070366) |
| 2.3 |
9.3 |
GO:0071280 |
cellular response to copper ion(GO:0071280) |
| 2.3 |
20.7 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 2.3 |
11.5 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 2.3 |
2.3 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 2.2 |
11.0 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 2.2 |
11.0 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 2.2 |
11.0 |
GO:0045918 |
negative regulation of cytolysis(GO:0045918) |
| 2.2 |
6.5 |
GO:0071336 |
regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 2.2 |
2.2 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 2.2 |
6.5 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 2.2 |
4.3 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 2.1 |
17.1 |
GO:0070447 |
positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 2.1 |
6.4 |
GO:2000562 |
negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 2.1 |
6.3 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 2.1 |
8.3 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 2.1 |
6.2 |
GO:0072180 |
mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 2.0 |
6.1 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 2.0 |
2.0 |
GO:0072199 |
mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) |
| 2.0 |
8.1 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 2.0 |
6.0 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 2.0 |
2.0 |
GO:0021913 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 2.0 |
2.0 |
GO:1901979 |
regulation of inward rectifier potassium channel activity(GO:1901979) |
| 2.0 |
5.9 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 1.9 |
1.9 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 1.9 |
1.9 |
GO:2000345 |
regulation of hepatocyte proliferation(GO:2000345) |
| 1.9 |
5.7 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 1.9 |
7.6 |
GO:0061526 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
| 1.9 |
19.0 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 1.9 |
1.9 |
GO:0071726 |
response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
| 1.9 |
5.6 |
GO:1903279 |
regulation of calcium:sodium antiporter activity(GO:1903279) |
| 1.9 |
5.6 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 1.8 |
1.8 |
GO:0045741 |
positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 1.8 |
3.6 |
GO:0010533 |
regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) |
| 1.8 |
5.3 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 1.7 |
3.5 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 1.7 |
5.2 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 1.7 |
5.2 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 1.7 |
6.8 |
GO:0010046 |
response to mycotoxin(GO:0010046) |
| 1.7 |
8.5 |
GO:0075136 |
response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 1.7 |
22.1 |
GO:0021892 |
cerebral cortex GABAergic interneuron differentiation(GO:0021892) |
| 1.7 |
5.1 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 1.7 |
10.1 |
GO:0032811 |
negative regulation of epinephrine secretion(GO:0032811) |
| 1.7 |
5.0 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 1.7 |
23.2 |
GO:0007190 |
activation of adenylate cyclase activity(GO:0007190) |
| 1.7 |
3.3 |
GO:1903596 |
regulation of gap junction assembly(GO:1903596) |
| 1.6 |
6.6 |
GO:0003430 |
growth plate cartilage chondrocyte growth(GO:0003430) |
| 1.6 |
4.9 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 1.6 |
4.9 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 1.6 |
1.6 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 1.6 |
4.8 |
GO:0015816 |
glycine transport(GO:0015816) |
| 1.6 |
8.0 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 1.6 |
1.6 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) |
| 1.6 |
4.7 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 1.6 |
4.7 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 1.6 |
4.7 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 1.6 |
3.1 |
GO:0070346 |
positive regulation of fat cell proliferation(GO:0070346) |
| 1.6 |
4.7 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 1.6 |
1.6 |
GO:0035799 |
ureter maturation(GO:0035799) |
| 1.6 |
3.1 |
GO:0060437 |
lung growth(GO:0060437) |
| 1.5 |
12.3 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 1.5 |
4.6 |
GO:0006507 |
GPI anchor release(GO:0006507) |
| 1.5 |
6.1 |
GO:2000065 |
negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 1.5 |
3.1 |
GO:0031394 |
positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
| 1.5 |
3.0 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 1.5 |
1.5 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 1.5 |
1.5 |
GO:0048611 |
ectodermal digestive tract development(GO:0007439) embryonic ectodermal digestive tract development(GO:0048611) |
| 1.5 |
6.1 |
GO:0072061 |
inner medullary collecting duct development(GO:0072061) |
| 1.5 |
10.6 |
GO:2000598 |
regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
| 1.5 |
10.5 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 1.5 |
6.0 |
GO:0060265 |
positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 1.5 |
4.5 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 1.5 |
3.0 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 1.5 |
4.5 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 1.5 |
4.5 |
GO:0010989 |
negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
| 1.5 |
2.9 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 1.5 |
2.9 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 1.5 |
1.5 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 1.5 |
1.5 |
GO:0070428 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
| 1.4 |
2.9 |
GO:0061043 |
regulation of vascular wound healing(GO:0061043) |
| 1.4 |
5.8 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 1.4 |
4.3 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 1.4 |
8.7 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 1.4 |
1.4 |
GO:0033092 |
positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 1.4 |
5.8 |
GO:0002924 |
negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
| 1.4 |
1.4 |
GO:0044650 |
virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
| 1.4 |
15.8 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 1.4 |
4.3 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 1.4 |
1.4 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 1.4 |
4.3 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 1.4 |
2.9 |
GO:0045915 |
positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 1.4 |
2.8 |
GO:1902109 |
negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 1.4 |
1.4 |
GO:0061304 |
retinal blood vessel morphogenesis(GO:0061304) |
| 1.4 |
2.8 |
GO:0021886 |
hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 1.4 |
9.8 |
GO:0032471 |
negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 1.4 |
2.8 |
GO:1900126 |
negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 1.4 |
2.8 |
GO:0045777 |
positive regulation of blood pressure(GO:0045777) |
| 1.4 |
1.4 |
GO:0072203 |
cell proliferation involved in metanephros development(GO:0072203) |
| 1.4 |
4.1 |
GO:2000813 |
negative regulation of barbed-end actin filament capping(GO:2000813) |
| 1.4 |
2.8 |
GO:2000822 |
regulation of fear response(GO:1903365) regulation of behavioral fear response(GO:2000822) |
| 1.4 |
6.9 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 1.4 |
5.5 |
GO:2001245 |
regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 1.4 |
1.4 |
GO:0033024 |
mast cell homeostasis(GO:0033023) mast cell apoptotic process(GO:0033024) regulation of mast cell apoptotic process(GO:0033025) |
| 1.4 |
1.4 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 1.4 |
10.9 |
GO:0033008 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 1.4 |
8.1 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 1.3 |
4.0 |
GO:1903244 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 1.3 |
4.0 |
GO:0014738 |
regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 1.3 |
1.3 |
GO:0097114 |
NMDA glutamate receptor clustering(GO:0097114) |
| 1.3 |
2.7 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 1.3 |
1.3 |
GO:0009182 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) GDP metabolic process(GO:0046710) |
| 1.3 |
1.3 |
GO:0051542 |
elastin biosynthetic process(GO:0051542) |
| 1.3 |
9.3 |
GO:0002283 |
neutrophil activation involved in immune response(GO:0002283) |
| 1.3 |
1.3 |
GO:0044070 |
regulation of anion transport(GO:0044070) |
| 1.3 |
4.0 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 1.3 |
2.6 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 1.3 |
5.3 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 1.3 |
1.3 |
GO:1902474 |
positive regulation of protein localization to synapse(GO:1902474) |
| 1.3 |
9.1 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 1.3 |
11.7 |
GO:0060371 |
regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
| 1.3 |
1.3 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 1.3 |
3.9 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 1.3 |
1.3 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 1.3 |
7.7 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
| 1.3 |
14.0 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 1.3 |
3.8 |
GO:0019043 |
establishment of viral latency(GO:0019043) |
| 1.3 |
6.3 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 1.3 |
1.3 |
GO:0001922 |
B-1 B cell homeostasis(GO:0001922) |
| 1.3 |
2.5 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 1.3 |
5.0 |
GO:0051708 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) cytosol to ER transport(GO:0046967) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 1.2 |
5.0 |
GO:0021586 |
pons maturation(GO:0021586) |
| 1.2 |
3.7 |
GO:0030070 |
insulin processing(GO:0030070) |
| 1.2 |
1.2 |
GO:0006533 |
aspartate catabolic process(GO:0006533) |
| 1.2 |
5.0 |
GO:0072369 |
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 1.2 |
5.0 |
GO:1903181 |
regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 1.2 |
2.5 |
GO:0045922 |
negative regulation of fatty acid metabolic process(GO:0045922) |
| 1.2 |
3.7 |
GO:0048819 |
regulation of hair follicle maturation(GO:0048819) regulation of catagen(GO:0051794) |
| 1.2 |
12.4 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 1.2 |
3.7 |
GO:0014050 |
negative regulation of glutamate secretion(GO:0014050) |
| 1.2 |
9.8 |
GO:0071468 |
cellular response to acidic pH(GO:0071468) |
| 1.2 |
3.7 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
| 1.2 |
3.6 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 1.2 |
3.6 |
GO:0019732 |
antifungal humoral response(GO:0019732) |
| 1.2 |
4.8 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 1.2 |
4.8 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 1.2 |
6.0 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 1.2 |
1.2 |
GO:0032341 |
mineralocorticoid metabolic process(GO:0008212) aldosterone metabolic process(GO:0032341) |
| 1.2 |
8.4 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 1.2 |
2.4 |
GO:2000551 |
regulation of T-helper 2 cell cytokine production(GO:2000551) positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
| 1.2 |
2.4 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 1.2 |
3.6 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 1.2 |
3.6 |
GO:0048866 |
stem cell fate specification(GO:0048866) |
| 1.2 |
1.2 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 1.2 |
9.3 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 1.2 |
5.8 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 1.2 |
1.2 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 1.2 |
2.3 |
GO:0071806 |
intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
| 1.2 |
3.5 |
GO:0002159 |
desmosome assembly(GO:0002159) |
| 1.1 |
1.1 |
GO:0018307 |
enzyme active site formation(GO:0018307) |
| 1.1 |
11.5 |
GO:0015824 |
proline transport(GO:0015824) |
| 1.1 |
4.6 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 1.1 |
6.8 |
GO:0071880 |
adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 1.1 |
10.2 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 1.1 |
2.3 |
GO:1900736 |
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 1.1 |
11.3 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 1.1 |
1.1 |
GO:0048711 |
positive regulation of astrocyte differentiation(GO:0048711) |
| 1.1 |
2.3 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
| 1.1 |
2.3 |
GO:0032328 |
alanine transport(GO:0032328) |
| 1.1 |
9.0 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 1.1 |
3.4 |
GO:0002586 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 1.1 |
21.2 |
GO:2000311 |
regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 1.1 |
1.1 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 1.1 |
3.3 |
GO:0097402 |
neuroblast migration(GO:0097402) |
| 1.1 |
5.6 |
GO:0003093 |
regulation of glomerular filtration(GO:0003093) |
| 1.1 |
3.3 |
GO:0045014 |
carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 1.1 |
5.5 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
| 1.1 |
1.1 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 1.1 |
4.4 |
GO:0071071 |
regulation of phospholipid biosynthetic process(GO:0071071) |
| 1.1 |
7.7 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) |
| 1.1 |
1.1 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 1.1 |
3.3 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 1.1 |
4.3 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 1.1 |
2.2 |
GO:2001016 |
positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 1.1 |
4.3 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 1.1 |
1.1 |
GO:0048289 |
isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
| 1.1 |
1.1 |
GO:1902548 |
negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 1.1 |
2.1 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 1.1 |
3.2 |
GO:0034650 |
cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
| 1.1 |
2.1 |
GO:0032960 |
regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
| 1.1 |
14.9 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 1.1 |
3.2 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 1.1 |
7.4 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 1.1 |
4.2 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 1.1 |
3.2 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 1.1 |
5.3 |
GO:2001025 |
positive regulation of response to drug(GO:2001025) |
| 1.1 |
3.2 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 1.0 |
1.0 |
GO:0002339 |
B cell selection(GO:0002339) |
| 1.0 |
3.1 |
GO:0060373 |
regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
| 1.0 |
2.1 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 1.0 |
8.3 |
GO:0014824 |
artery smooth muscle contraction(GO:0014824) |
| 1.0 |
2.1 |
GO:2000224 |
testosterone biosynthetic process(GO:0061370) regulation of testosterone biosynthetic process(GO:2000224) |
| 1.0 |
3.1 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 1.0 |
3.1 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 1.0 |
3.1 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 1.0 |
15.5 |
GO:0006883 |
cellular sodium ion homeostasis(GO:0006883) |
| 1.0 |
3.1 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 1.0 |
7.2 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 1.0 |
8.2 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 1.0 |
3.1 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 1.0 |
5.1 |
GO:1903275 |
positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
| 1.0 |
5.1 |
GO:0014048 |
regulation of glutamate secretion(GO:0014048) |
| 1.0 |
3.1 |
GO:0014826 |
vein smooth muscle contraction(GO:0014826) |
| 1.0 |
6.1 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 1.0 |
5.0 |
GO:0036115 |
fatty-acyl-CoA catabolic process(GO:0036115) |
| 1.0 |
2.0 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 1.0 |
5.0 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 1.0 |
3.0 |
GO:0070296 |
sarcoplasmic reticulum calcium ion transport(GO:0070296) |
| 1.0 |
1.0 |
GO:1903525 |
regulation of membrane tubulation(GO:1903525) |
| 1.0 |
8.0 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 1.0 |
1.0 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 1.0 |
11.9 |
GO:0045217 |
cell-cell junction maintenance(GO:0045217) |
| 1.0 |
3.0 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 1.0 |
6.0 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 1.0 |
4.0 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 1.0 |
5.0 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 1.0 |
2.0 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 1.0 |
7.9 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 1.0 |
4.9 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 1.0 |
1.0 |
GO:0002553 |
histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 1.0 |
3.0 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 1.0 |
2.9 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 1.0 |
4.9 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 1.0 |
2.9 |
GO:0010896 |
regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
| 1.0 |
1.0 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil activation(GO:0043307) eosinophil degranulation(GO:0043308) |
| 1.0 |
1.0 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 1.0 |
6.8 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 1.0 |
2.9 |
GO:1990035 |
calcium ion import into cell(GO:1990035) |
| 1.0 |
2.9 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.0 |
1.0 |
GO:0046543 |
development of secondary sexual characteristics(GO:0045136) development of secondary female sexual characteristics(GO:0046543) |
| 1.0 |
2.9 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 1.0 |
4.8 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 1.0 |
1.0 |
GO:0043096 |
purine nucleobase salvage(GO:0043096) |
| 1.0 |
1.9 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 1.0 |
1.0 |
GO:1904008 |
response to monosodium glutamate(GO:1904008) cellular response to monosodium glutamate(GO:1904009) |
| 1.0 |
12.4 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 1.0 |
1.9 |
GO:0090192 |
regulation of glomerulus development(GO:0090192) |
| 0.9 |
2.8 |
GO:0045659 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.9 |
9.5 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.9 |
0.9 |
GO:0010873 |
positive regulation of cholesterol esterification(GO:0010873) |
| 0.9 |
7.6 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.9 |
5.7 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.9 |
1.9 |
GO:0070488 |
neutrophil aggregation(GO:0070488) |
| 0.9 |
3.8 |
GO:0003025 |
regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.9 |
1.9 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
| 0.9 |
22.6 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.9 |
2.8 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.9 |
2.8 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.9 |
3.7 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.9 |
6.5 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.9 |
4.7 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.9 |
0.9 |
GO:0046958 |
nonassociative learning(GO:0046958) habituation(GO:0046959) |
| 0.9 |
1.9 |
GO:2000172 |
regulation of branching morphogenesis of a nerve(GO:2000172) |
| 0.9 |
1.9 |
GO:0048168 |
regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.9 |
0.9 |
GO:0006702 |
androgen biosynthetic process(GO:0006702) |
| 0.9 |
2.8 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.9 |
3.7 |
GO:0016082 |
synaptic vesicle priming(GO:0016082) |
| 0.9 |
14.7 |
GO:2000251 |
positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.9 |
8.3 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.9 |
1.8 |
GO:0047484 |
regulation of response to osmotic stress(GO:0047484) |
| 0.9 |
3.7 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 0.9 |
2.7 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.9 |
3.6 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.9 |
0.9 |
GO:0051608 |
histamine transport(GO:0051608) |
| 0.9 |
3.6 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.9 |
0.9 |
GO:0032829 |
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
| 0.9 |
1.8 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.9 |
0.9 |
GO:0048630 |
skeletal muscle tissue growth(GO:0048630) |
| 0.9 |
3.6 |
GO:0006848 |
pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.9 |
15.3 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.9 |
0.9 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.9 |
0.9 |
GO:0061082 |
positive regulation of cytokine production involved in immune response(GO:0002720) myeloid leukocyte cytokine production(GO:0061082) |
| 0.9 |
2.7 |
GO:0034124 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 0.9 |
2.7 |
GO:0045629 |
negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.9 |
2.7 |
GO:0097491 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 0.9 |
9.8 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.9 |
1.8 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
| 0.9 |
3.6 |
GO:0034766 |
negative regulation of ion transmembrane transport(GO:0034766) |
| 0.9 |
0.9 |
GO:0030223 |
neutrophil differentiation(GO:0030223) |
| 0.9 |
2.7 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.9 |
5.3 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.9 |
0.9 |
GO:0038171 |
cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
| 0.9 |
0.9 |
GO:0050951 |
sensory perception of temperature stimulus(GO:0050951) |
| 0.9 |
9.7 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.9 |
2.6 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.9 |
6.1 |
GO:0031645 |
negative regulation of neurological system process(GO:0031645) |
| 0.9 |
2.6 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.9 |
2.6 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.9 |
3.5 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.9 |
3.5 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.9 |
0.9 |
GO:2000670 |
positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.9 |
1.7 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 0.9 |
1.7 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.9 |
2.6 |
GO:0002940 |
tRNA N2-guanine methylation(GO:0002940) |
| 0.9 |
0.9 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.9 |
2.6 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.9 |
4.3 |
GO:1903307 |
positive regulation of regulated secretory pathway(GO:1903307) |
| 0.9 |
8.6 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.9 |
0.9 |
GO:0009110 |
vitamin biosynthetic process(GO:0009110) |
| 0.9 |
4.3 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.9 |
5.1 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
| 0.9 |
11.1 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.9 |
2.6 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.8 |
2.5 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.8 |
2.5 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.8 |
2.5 |
GO:0008050 |
courtship behavior(GO:0007619) female courtship behavior(GO:0008050) negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 0.8 |
0.8 |
GO:0071895 |
odontoblast differentiation(GO:0071895) |
| 0.8 |
5.9 |
GO:0090170 |
regulation of Golgi inheritance(GO:0090170) |
| 0.8 |
3.4 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 0.8 |
0.8 |
GO:0030538 |
embryonic genitalia morphogenesis(GO:0030538) embryonic hindgut morphogenesis(GO:0048619) |
| 0.8 |
5.0 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.8 |
3.4 |
GO:0009227 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) nucleotide-sugar catabolic process(GO:0009227) |
| 0.8 |
0.8 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.8 |
6.7 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.8 |
1.7 |
GO:0072643 |
interferon-gamma secretion(GO:0072643) |
| 0.8 |
16.7 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.8 |
2.5 |
GO:0060672 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.8 |
2.5 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.8 |
0.8 |
GO:0014831 |
gastro-intestinal system smooth muscle contraction(GO:0014831) |
| 0.8 |
3.3 |
GO:0001973 |
adenosine receptor signaling pathway(GO:0001973) |
| 0.8 |
8.2 |
GO:0002323 |
natural killer cell activation involved in immune response(GO:0002323) |
| 0.8 |
5.7 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.8 |
7.4 |
GO:0001765 |
membrane raft assembly(GO:0001765) |
| 0.8 |
0.8 |
GO:0002765 |
immune response-inhibiting signal transduction(GO:0002765) |
| 0.8 |
2.5 |
GO:0060453 |
regulation of gastric acid secretion(GO:0060453) |
| 0.8 |
2.4 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.8 |
2.4 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.8 |
0.8 |
GO:0060913 |
cardiac cell fate determination(GO:0060913) |
| 0.8 |
0.8 |
GO:0097500 |
receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.8 |
0.8 |
GO:0051029 |
rRNA transport(GO:0051029) |
| 0.8 |
6.5 |
GO:2000489 |
hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
| 0.8 |
1.6 |
GO:0034310 |
primary alcohol catabolic process(GO:0034310) |
| 0.8 |
2.4 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.8 |
4.0 |
GO:0018002 |
N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.8 |
4.0 |
GO:1904721 |
regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 0.8 |
1.6 |
GO:0051590 |
positive regulation of neurotransmitter transport(GO:0051590) |
| 0.8 |
2.4 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.8 |
2.4 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.8 |
3.2 |
GO:0007023 |
post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.8 |
2.4 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.8 |
0.8 |
GO:0042275 |
error-free postreplication DNA repair(GO:0042275) |
| 0.8 |
2.4 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.8 |
3.2 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.8 |
5.5 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.8 |
0.8 |
GO:0010692 |
regulation of alkaline phosphatase activity(GO:0010692) |
| 0.8 |
4.7 |
GO:0061718 |
NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.8 |
5.5 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.8 |
1.6 |
GO:0009169 |
purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
| 0.8 |
4.7 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.8 |
8.6 |
GO:0042711 |
maternal behavior(GO:0042711) |
| 0.8 |
1.6 |
GO:0010958 |
regulation of amino acid import(GO:0010958) regulation of L-arginine import(GO:0010963) |
| 0.8 |
2.3 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.8 |
3.1 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.8 |
0.8 |
GO:0032463 |
negative regulation of protein homooligomerization(GO:0032463) |
| 0.8 |
0.8 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.8 |
6.9 |
GO:0060052 |
neurofilament cytoskeleton organization(GO:0060052) |
| 0.8 |
3.1 |
GO:0010813 |
neuropeptide catabolic process(GO:0010813) |
| 0.8 |
2.3 |
GO:1900623 |
regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
| 0.8 |
2.3 |
GO:0014743 |
regulation of muscle hypertrophy(GO:0014743) |
| 0.8 |
3.1 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.8 |
0.8 |
GO:0050859 |
negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.8 |
0.8 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.8 |
6.1 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.8 |
8.4 |
GO:1990173 |
protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
| 0.8 |
1.5 |
GO:1903223 |
positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.8 |
5.3 |
GO:0090336 |
positive regulation of brown fat cell differentiation(GO:0090336) |
| 0.8 |
0.8 |
GO:1900110 |
negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 0.8 |
9.8 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.8 |
0.8 |
GO:0033032 |
regulation of myeloid cell apoptotic process(GO:0033032) |
| 0.8 |
9.8 |
GO:0021527 |
spinal cord association neuron differentiation(GO:0021527) |
| 0.8 |
6.8 |
GO:0048678 |
response to axon injury(GO:0048678) |
| 0.8 |
13.5 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.8 |
3.0 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.8 |
3.0 |
GO:0015786 |
UDP-glucose transport(GO:0015786) |
| 0.8 |
9.0 |
GO:0050765 |
negative regulation of phagocytosis(GO:0050765) |
| 0.8 |
0.8 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.7 |
6.7 |
GO:0033599 |
regulation of mammary gland epithelial cell proliferation(GO:0033599) |
| 0.7 |
4.5 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.7 |
2.2 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.7 |
3.7 |
GO:0071474 |
cellular hyperosmotic response(GO:0071474) |
| 0.7 |
3.7 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.7 |
1.5 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 0.7 |
0.7 |
GO:0032700 |
negative regulation of interleukin-17 production(GO:0032700) |
| 0.7 |
2.2 |
GO:0038179 |
neurotrophin signaling pathway(GO:0038179) |
| 0.7 |
5.2 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.7 |
0.7 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.7 |
0.7 |
GO:0006541 |
glutamine metabolic process(GO:0006541) |
| 0.7 |
2.2 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 0.7 |
5.1 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.7 |
2.9 |
GO:1901164 |
negative regulation of trophoblast cell migration(GO:1901164) |
| 0.7 |
16.1 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.7 |
2.2 |
GO:0045776 |
negative regulation of blood pressure(GO:0045776) |
| 0.7 |
1.5 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.7 |
8.0 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.7 |
1.5 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.7 |
2.9 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.7 |
0.7 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.7 |
18.1 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.7 |
7.2 |
GO:2000649 |
regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.7 |
1.4 |
GO:0070166 |
enamel mineralization(GO:0070166) |
| 0.7 |
0.7 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 0.7 |
4.3 |
GO:0046103 |
inosine biosynthetic process(GO:0046103) |
| 0.7 |
0.7 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.7 |
3.6 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.7 |
10.0 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.7 |
0.7 |
GO:0010752 |
regulation of cGMP-mediated signaling(GO:0010752) |
| 0.7 |
2.1 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 0.7 |
1.4 |
GO:0032847 |
regulation of cellular pH reduction(GO:0032847) |
| 0.7 |
5.0 |
GO:0070458 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 0.7 |
9.9 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.7 |
3.5 |
GO:0043416 |
regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.7 |
13.4 |
GO:0000028 |
ribosomal small subunit assembly(GO:0000028) |
| 0.7 |
1.4 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.7 |
0.7 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.7 |
2.1 |
GO:0042045 |
epithelial fluid transport(GO:0042045) |
| 0.7 |
2.1 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
| 0.7 |
0.7 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 0.7 |
2.1 |
GO:0033030 |
negative regulation of neutrophil apoptotic process(GO:0033030) |
| 0.7 |
0.7 |
GO:0042637 |
catagen(GO:0042637) |
| 0.7 |
1.4 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.7 |
2.8 |
GO:2000830 |
vacuolar phosphate transport(GO:0007037) vitamin D3 metabolic process(GO:0070640) regulation of parathyroid hormone secretion(GO:2000828) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 0.7 |
3.5 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.7 |
7.7 |
GO:0051930 |
regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.7 |
2.8 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.7 |
7.6 |
GO:0045063 |
T-helper 1 cell differentiation(GO:0045063) |
| 0.7 |
3.5 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.7 |
4.2 |
GO:0090241 |
negative regulation of histone H4 acetylation(GO:0090241) |
| 0.7 |
0.7 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.7 |
4.1 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.7 |
2.1 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.7 |
1.4 |
GO:0051482 |
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
| 0.7 |
3.4 |
GO:0010454 |
negative regulation of cell fate commitment(GO:0010454) |
| 0.7 |
2.7 |
GO:0051004 |
regulation of lipoprotein lipase activity(GO:0051004) |
| 0.7 |
2.7 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.7 |
2.7 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.7 |
1.4 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.7 |
0.7 |
GO:2000823 |
regulation of androgen receptor activity(GO:2000823) |
| 0.7 |
2.7 |
GO:0035927 |
RNA import into mitochondrion(GO:0035927) |
| 0.7 |
2.7 |
GO:0086013 |
membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
| 0.7 |
4.1 |
GO:0006113 |
fermentation(GO:0006113) |
| 0.7 |
1.4 |
GO:0036166 |
phenotypic switching(GO:0036166) |
| 0.7 |
0.7 |
GO:1902600 |
hydrogen ion transmembrane transport(GO:1902600) |
| 0.7 |
3.4 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.7 |
2.7 |
GO:0033600 |
negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.7 |
4.1 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.7 |
2.0 |
GO:0006207 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.7 |
1.3 |
GO:1902913 |
regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) positive regulation of developmental pigmentation(GO:0048087) regulation of pigment cell differentiation(GO:0050932) positive regulation of pigment cell differentiation(GO:0050942) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.7 |
0.7 |
GO:0021593 |
rhombomere morphogenesis(GO:0021593) |
| 0.7 |
3.4 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.7 |
2.7 |
GO:1902224 |
cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
| 0.7 |
0.7 |
GO:0002371 |
dendritic cell cytokine production(GO:0002371) regulation of dendritic cell cytokine production(GO:0002730) |
| 0.7 |
7.4 |
GO:0002031 |
G-protein coupled receptor internalization(GO:0002031) |
| 0.7 |
4.7 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.7 |
3.3 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.7 |
0.7 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.7 |
5.3 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.7 |
0.7 |
GO:0045112 |
integrin biosynthetic process(GO:0045112) |
| 0.7 |
2.7 |
GO:0033580 |
protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.7 |
0.7 |
GO:0002866 |
positive regulation of acute inflammatory response to antigenic stimulus(GO:0002866) |
| 0.7 |
2.7 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.7 |
5.3 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 0.7 |
1.3 |
GO:0010572 |
positive regulation of platelet activation(GO:0010572) |
| 0.7 |
0.7 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.7 |
2.0 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
| 0.7 |
0.7 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.7 |
3.9 |
GO:0016255 |
attachment of GPI anchor to protein(GO:0016255) |
| 0.7 |
3.9 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.7 |
2.6 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.7 |
3.3 |
GO:0006564 |
L-serine biosynthetic process(GO:0006564) |
| 0.7 |
2.0 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.7 |
0.7 |
GO:0072008 |
glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
| 0.7 |
1.3 |
GO:0090343 |
positive regulation of cell aging(GO:0090343) |
| 0.7 |
0.7 |
GO:1903975 |
regulation of glial cell migration(GO:1903975) |
| 0.7 |
7.2 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.7 |
0.7 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.6 |
1.9 |
GO:1902172 |
keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.6 |
1.9 |
GO:0001771 |
immunological synapse formation(GO:0001771) |
| 0.6 |
1.9 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.6 |
1.9 |
GO:0044791 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.6 |
1.9 |
GO:0071872 |
response to epinephrine(GO:0071871) cellular response to epinephrine stimulus(GO:0071872) |
| 0.6 |
3.8 |
GO:0061051 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.6 |
1.9 |
GO:0046166 |
glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.6 |
6.4 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.6 |
10.2 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.6 |
2.6 |
GO:0007193 |
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.6 |
2.5 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.6 |
5.7 |
GO:0030049 |
muscle filament sliding(GO:0030049) |
| 0.6 |
2.5 |
GO:0006659 |
phosphatidylserine biosynthetic process(GO:0006659) |
| 0.6 |
1.9 |
GO:0009247 |
glycolipid biosynthetic process(GO:0009247) |
| 0.6 |
1.9 |
GO:0000050 |
urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
| 0.6 |
5.1 |
GO:0071816 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.6 |
0.6 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.6 |
5.1 |
GO:0010759 |
positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.6 |
1.9 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 0.6 |
2.5 |
GO:0019370 |
leukotriene biosynthetic process(GO:0019370) |
| 0.6 |
1.9 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.6 |
3.8 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.6 |
0.6 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.6 |
4.4 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.6 |
3.1 |
GO:0070474 |
positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.6 |
0.6 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.6 |
3.7 |
GO:0019346 |
homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 0.6 |
1.2 |
GO:0048069 |
eye pigmentation(GO:0048069) |
| 0.6 |
0.6 |
GO:1903207 |
neuron death in response to hydrogen peroxide(GO:0036476) neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) negative regulation of mitochondrial fission(GO:0090258) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
| 0.6 |
1.2 |
GO:0008078 |
mesodermal cell migration(GO:0008078) |
| 0.6 |
1.9 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.6 |
0.6 |
GO:1902608 |
regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
| 0.6 |
2.5 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.6 |
2.5 |
GO:0045163 |
clustering of voltage-gated potassium channels(GO:0045163) |
| 0.6 |
2.4 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.6 |
3.7 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.6 |
1.8 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.6 |
1.2 |
GO:0070099 |
regulation of chemokine-mediated signaling pathway(GO:0070099) |
| 0.6 |
1.2 |
GO:0001866 |
NK T cell proliferation(GO:0001866) |
| 0.6 |
1.2 |
GO:0048597 |
post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.6 |
2.4 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.6 |
5.5 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.6 |
1.2 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) norepinephrine transport(GO:0015874) |
| 0.6 |
4.2 |
GO:0006363 |
termination of RNA polymerase I transcription(GO:0006363) |
| 0.6 |
1.8 |
GO:1902308 |
regulation of peptidyl-serine dephosphorylation(GO:1902308) |
| 0.6 |
5.4 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.6 |
1.8 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.6 |
1.8 |
GO:0043181 |
diaphragm contraction(GO:0002086) vacuolar sequestering(GO:0043181) |
| 0.6 |
1.2 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.6 |
0.6 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.6 |
0.6 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.6 |
0.6 |
GO:0002888 |
positive regulation of myeloid leukocyte mediated immunity(GO:0002888) |
| 0.6 |
1.2 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 0.6 |
3.5 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.6 |
1.8 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.6 |
2.3 |
GO:0071236 |
cellular response to antibiotic(GO:0071236) |
| 0.6 |
0.6 |
GO:0061013 |
regulation of mRNA catabolic process(GO:0061013) |
| 0.6 |
1.8 |
GO:0042220 |
response to cocaine(GO:0042220) behavioral response to cocaine(GO:0048148) |
| 0.6 |
1.2 |
GO:0032725 |
positive regulation of granulocyte macrophage colony-stimulating factor production(GO:0032725) |
| 0.6 |
1.8 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.6 |
2.3 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 0.6 |
1.2 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.6 |
2.3 |
GO:0042403 |
thyroid hormone metabolic process(GO:0042403) |
| 0.6 |
2.3 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.6 |
2.3 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.6 |
0.6 |
GO:1902861 |
copper ion import into cell(GO:1902861) |
| 0.6 |
9.3 |
GO:0048169 |
regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.6 |
0.6 |
GO:0060161 |
positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.6 |
4.6 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.6 |
14.4 |
GO:0045746 |
negative regulation of Notch signaling pathway(GO:0045746) |
| 0.6 |
0.6 |
GO:0060710 |
chorio-allantoic fusion(GO:0060710) |
| 0.6 |
2.9 |
GO:0031953 |
negative regulation of protein autophosphorylation(GO:0031953) |
| 0.6 |
6.9 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.6 |
2.3 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.6 |
0.6 |
GO:1904152 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.6 |
2.8 |
GO:1903358 |
regulation of Golgi organization(GO:1903358) |
| 0.6 |
1.7 |
GO:0090529 |
barrier septum assembly(GO:0000917) cell septum assembly(GO:0090529) |
| 0.6 |
0.6 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.6 |
1.7 |
GO:2000857 |
positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.6 |
19.2 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.6 |
4.5 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.6 |
1.7 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.6 |
1.1 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.6 |
1.1 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.6 |
0.6 |
GO:0010991 |
negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.6 |
1.7 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.6 |
1.1 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.6 |
1.7 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.6 |
2.2 |
GO:0000447 |
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.6 |
1.7 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.6 |
1.7 |
GO:0032079 |
positive regulation of endodeoxyribonuclease activity(GO:0032079) |
| 0.6 |
5.5 |
GO:0002091 |
negative regulation of receptor internalization(GO:0002091) |
| 0.6 |
2.2 |
GO:0061626 |
pharyngeal arch artery morphogenesis(GO:0061626) |
| 0.6 |
1.7 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.6 |
2.8 |
GO:0045144 |
meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
| 0.6 |
9.9 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.6 |
9.9 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.5 |
3.3 |
GO:0006122 |
mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.5 |
1.6 |
GO:0051541 |
elastin metabolic process(GO:0051541) |
| 0.5 |
0.5 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 0.5 |
4.4 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.5 |
0.5 |
GO:0050913 |
sensory perception of bitter taste(GO:0050913) |
| 0.5 |
3.2 |
GO:0006654 |
phosphatidic acid biosynthetic process(GO:0006654) phosphatidic acid metabolic process(GO:0046473) |
| 0.5 |
3.2 |
GO:0051205 |
protein insertion into membrane(GO:0051205) |
| 0.5 |
9.2 |
GO:0046185 |
aldehyde catabolic process(GO:0046185) |
| 0.5 |
1.6 |
GO:0046016 |
positive regulation of transcription by glucose(GO:0046016) |
| 0.5 |
2.1 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.5 |
2.7 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.5 |
3.2 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.5 |
1.6 |
GO:0010737 |
protein kinase A signaling(GO:0010737) |
| 0.5 |
0.5 |
GO:1901163 |
trophoblast cell migration(GO:0061450) regulation of trophoblast cell migration(GO:1901163) |
| 0.5 |
8.5 |
GO:0033198 |
response to ATP(GO:0033198) |
| 0.5 |
0.5 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.5 |
0.5 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.5 |
3.7 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.5 |
7.4 |
GO:0010388 |
cullin deneddylation(GO:0010388) |
| 0.5 |
3.7 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.5 |
0.5 |
GO:0042182 |
ketone catabolic process(GO:0042182) |
| 0.5 |
1.1 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.5 |
12.7 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 0.5 |
1.1 |
GO:0003057 |
regulation of the force of heart contraction by chemical signal(GO:0003057) |
| 0.5 |
1.6 |
GO:0033561 |
regulation of water loss via skin(GO:0033561) |
| 0.5 |
2.1 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.5 |
2.1 |
GO:0050819 |
negative regulation of coagulation(GO:0050819) |
| 0.5 |
2.6 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.5 |
1.0 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.5 |
2.1 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.5 |
1.5 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.5 |
2.1 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) ether lipid metabolic process(GO:0046485) |
| 0.5 |
5.7 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.5 |
1.5 |
GO:0042228 |
interleukin-8 biosynthetic process(GO:0042228) |
| 0.5 |
1.0 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.5 |
2.6 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.5 |
2.6 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.5 |
8.2 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.5 |
1.5 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.5 |
1.5 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.5 |
2.5 |
GO:0002861 |
regulation of inflammatory response to antigenic stimulus(GO:0002861) |
| 0.5 |
0.5 |
GO:0097154 |
GABAergic neuron differentiation(GO:0097154) |
| 0.5 |
1.5 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.5 |
4.0 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.5 |
0.5 |
GO:0060416 |
response to growth hormone(GO:0060416) |
| 0.5 |
15.0 |
GO:0035456 |
response to interferon-beta(GO:0035456) |
| 0.5 |
2.0 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.5 |
2.5 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.5 |
1.5 |
GO:0051001 |
negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.5 |
1.0 |
GO:0046148 |
pigment biosynthetic process(GO:0046148) |
| 0.5 |
3.5 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.5 |
1.0 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.5 |
1.5 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.5 |
2.5 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.5 |
0.5 |
GO:2000644 |
regulation of receptor catabolic process(GO:2000644) |
| 0.5 |
0.5 |
GO:0015870 |
acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 0.5 |
20.1 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.5 |
1.0 |
GO:0051531 |
NFAT protein import into nucleus(GO:0051531) |
| 0.5 |
0.5 |
GO:0033572 |
transferrin transport(GO:0033572) |
| 0.5 |
2.9 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.5 |
1.9 |
GO:0046464 |
neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
| 0.5 |
1.9 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.5 |
1.0 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 0.5 |
1.9 |
GO:0006481 |
C-terminal protein methylation(GO:0006481) |
| 0.5 |
0.5 |
GO:0072319 |
vesicle uncoating(GO:0072319) |
| 0.5 |
14.0 |
GO:0018196 |
peptidyl-asparagine modification(GO:0018196) |
| 0.5 |
0.5 |
GO:1903722 |
regulation of centriole elongation(GO:1903722) |
| 0.5 |
4.3 |
GO:0060586 |
multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.5 |
1.0 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.5 |
3.4 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.5 |
1.0 |
GO:0035457 |
cellular response to interferon-alpha(GO:0035457) |
| 0.5 |
3.4 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.5 |
0.5 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.5 |
1.9 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.5 |
1.4 |
GO:0051968 |
positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
| 0.5 |
2.9 |
GO:1901837 |
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 0.5 |
2.9 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.5 |
1.0 |
GO:0039532 |
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.5 |
1.4 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.5 |
0.9 |
GO:0071941 |
nitrogen cycle metabolic process(GO:0071941) |
| 0.5 |
8.1 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.5 |
2.4 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.5 |
2.8 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.5 |
1.4 |
GO:1900060 |
negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.5 |
0.5 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.5 |
11.8 |
GO:0048662 |
negative regulation of smooth muscle cell proliferation(GO:0048662) |
| 0.5 |
2.4 |
GO:1902047 |
polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.5 |
3.8 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.5 |
1.4 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.5 |
6.6 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.5 |
0.5 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.5 |
0.5 |
GO:0090500 |
endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.5 |
1.4 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.5 |
1.4 |
GO:0043084 |
penile erection(GO:0043084) |
| 0.5 |
2.8 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.5 |
0.5 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.5 |
2.3 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.5 |
0.5 |
GO:0033239 |
negative regulation of cellular amine metabolic process(GO:0033239) |
| 0.5 |
0.9 |
GO:0008211 |
glucocorticoid metabolic process(GO:0008211) |
| 0.5 |
2.8 |
GO:0045806 |
negative regulation of endocytosis(GO:0045806) |
| 0.5 |
1.9 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.5 |
2.3 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.5 |
1.9 |
GO:0019348 |
dolichol metabolic process(GO:0019348) |
| 0.5 |
8.8 |
GO:0010862 |
positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.5 |
4.2 |
GO:0050832 |
defense response to fungus(GO:0050832) |
| 0.5 |
0.5 |
GO:0000720 |
pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.5 |
1.8 |
GO:0070584 |
mitochondrion morphogenesis(GO:0070584) |
| 0.5 |
1.8 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.5 |
0.5 |
GO:1901386 |
negative regulation of voltage-gated calcium channel activity(GO:1901386) |
| 0.5 |
0.5 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 0.5 |
0.9 |
GO:0010624 |
regulation of Schwann cell proliferation(GO:0010624) |
| 0.5 |
5.0 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.5 |
12.4 |
GO:0033014 |
porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.5 |
3.7 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.5 |
0.9 |
GO:1903772 |
regulation of viral budding via host ESCRT complex(GO:1903772) |
| 0.5 |
1.8 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.5 |
0.9 |
GO:0071455 |
cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
| 0.5 |
4.1 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.5 |
3.6 |
GO:0061154 |
endothelial tube morphogenesis(GO:0061154) |
| 0.5 |
0.5 |
GO:0099623 |
regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
| 0.5 |
0.9 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.5 |
0.9 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.5 |
7.3 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.5 |
1.8 |
GO:0001834 |
trophectodermal cell proliferation(GO:0001834) |
| 0.5 |
1.4 |
GO:0042102 |
positive regulation of T cell proliferation(GO:0042102) |
| 0.5 |
2.7 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.5 |
0.5 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.5 |
1.8 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.5 |
1.4 |
GO:0036336 |
dendritic cell migration(GO:0036336) |
| 0.5 |
0.9 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.5 |
0.5 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.4 |
1.3 |
GO:1904729 |
regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
| 0.4 |
9.4 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.4 |
5.4 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.4 |
3.1 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.4 |
0.9 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.4 |
9.0 |
GO:0019233 |
sensory perception of pain(GO:0019233) |
| 0.4 |
6.3 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.4 |
0.9 |
GO:0031638 |
zymogen activation(GO:0031638) |
| 0.4 |
1.3 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.4 |
1.8 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.4 |
0.9 |
GO:0097501 |
stress response to metal ion(GO:0097501) |
| 0.4 |
1.8 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.4 |
0.4 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.4 |
0.4 |
GO:0019042 |
viral latency(GO:0019042) |
| 0.4 |
2.7 |
GO:0042745 |
circadian sleep/wake cycle(GO:0042745) |
| 0.4 |
1.8 |
GO:0001845 |
phagolysosome assembly(GO:0001845) |
| 0.4 |
0.4 |
GO:0048023 |
positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
| 0.4 |
0.9 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 0.4 |
5.7 |
GO:1900454 |
positive regulation of long term synaptic depression(GO:1900454) |
| 0.4 |
1.3 |
GO:0050904 |
diapedesis(GO:0050904) |
| 0.4 |
3.5 |
GO:0032469 |
endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.4 |
0.9 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.4 |
1.3 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.4 |
3.0 |
GO:0034551 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.4 |
0.9 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.4 |
1.3 |
GO:0071544 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 0.4 |
1.7 |
GO:0000460 |
maturation of 5.8S rRNA(GO:0000460) |
| 0.4 |
1.7 |
GO:0007253 |
cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.4 |
2.6 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.4 |
0.9 |
GO:0071873 |
response to norepinephrine(GO:0071873) |
| 0.4 |
3.4 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.4 |
0.4 |
GO:0043950 |
positive regulation of cAMP-mediated signaling(GO:0043950) |
| 0.4 |
0.4 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.4 |
0.4 |
GO:0055091 |
phospholipid homeostasis(GO:0055091) |
| 0.4 |
0.4 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.4 |
0.8 |
GO:0050651 |
dermatan sulfate biosynthetic process(GO:0030208) dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.4 |
1.3 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.4 |
2.5 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.4 |
0.8 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 0.4 |
0.4 |
GO:0086046 |
membrane depolarization during SA node cell action potential(GO:0086046) |
| 0.4 |
0.4 |
GO:0072578 |
neurotransmitter-gated ion channel clustering(GO:0072578) |
| 0.4 |
0.4 |
GO:0035810 |
positive regulation of urine volume(GO:0035810) |
| 0.4 |
5.0 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.4 |
0.8 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.4 |
0.4 |
GO:0052428 |
modification by symbiont of host morphology or physiology(GO:0044003) modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.4 |
0.4 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.4 |
10.8 |
GO:0003073 |
regulation of systemic arterial blood pressure(GO:0003073) |
| 0.4 |
0.8 |
GO:0061588 |
calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.4 |
9.1 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.4 |
0.4 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.4 |
1.2 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.4 |
1.6 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.4 |
2.9 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.4 |
1.6 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.4 |
0.8 |
GO:0044034 |
negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.4 |
7.8 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.4 |
1.2 |
GO:0042534 |
tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 0.4 |
2.4 |
GO:0001759 |
organ induction(GO:0001759) |
| 0.4 |
2.4 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.4 |
3.7 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.4 |
1.2 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.4 |
2.0 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.4 |
0.8 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.4 |
1.6 |
GO:0033631 |
cell-cell adhesion mediated by integrin(GO:0033631) |
| 0.4 |
1.2 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.4 |
1.6 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.4 |
6.0 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.4 |
0.8 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin biosynthetic process(GO:0032049) |
| 0.4 |
2.8 |
GO:0008535 |
respiratory chain complex IV assembly(GO:0008535) mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.4 |
2.4 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.4 |
1.6 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.4 |
2.0 |
GO:0009642 |
response to light intensity(GO:0009642) |
| 0.4 |
1.6 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.4 |
0.4 |
GO:0071222 |
cellular response to lipopolysaccharide(GO:0071222) |
| 0.4 |
2.0 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.4 |
18.4 |
GO:0071230 |
cellular response to amino acid stimulus(GO:0071230) |
| 0.4 |
0.4 |
GO:0061535 |
glutamate secretion, neurotransmission(GO:0061535) |
| 0.4 |
2.3 |
GO:0043277 |
apoptotic cell clearance(GO:0043277) |
| 0.4 |
1.9 |
GO:0044794 |
positive regulation by host of viral process(GO:0044794) |
| 0.4 |
0.8 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.4 |
0.4 |
GO:2001268 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 0.4 |
2.7 |
GO:0032233 |
positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.4 |
1.9 |
GO:0071712 |
ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.4 |
0.8 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.4 |
0.8 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.4 |
0.8 |
GO:0009125 |
nucleoside monophosphate catabolic process(GO:0009125) |
| 0.4 |
1.1 |
GO:0031038 |
myosin II filament organization(GO:0031038) regulation of myosin II filament organization(GO:0043519) |
| 0.4 |
1.5 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.4 |
1.5 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.4 |
0.8 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.4 |
1.1 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.4 |
0.4 |
GO:1903224 |
regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
| 0.4 |
0.4 |
GO:0035509 |
negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
| 0.4 |
4.5 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.4 |
1.1 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.4 |
0.7 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.4 |
0.4 |
GO:1904238 |
pericyte cell differentiation(GO:1904238) |
| 0.4 |
0.4 |
GO:2000169 |
regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.4 |
4.8 |
GO:0030150 |
protein import into mitochondrial matrix(GO:0030150) |
| 0.4 |
0.7 |
GO:0006027 |
glycosaminoglycan catabolic process(GO:0006027) |
| 0.4 |
3.3 |
GO:0043496 |
regulation of protein homodimerization activity(GO:0043496) |
| 0.4 |
1.5 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.4 |
0.7 |
GO:0046618 |
drug export(GO:0046618) |
| 0.4 |
1.5 |
GO:0042590 |
antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
| 0.4 |
1.1 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.4 |
0.4 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.4 |
7.0 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.4 |
1.5 |
GO:0070574 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.4 |
3.6 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.4 |
1.5 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.4 |
2.5 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.4 |
1.4 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.4 |
0.7 |
GO:2000398 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.4 |
0.4 |
GO:0022028 |
tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
| 0.4 |
2.9 |
GO:0006693 |
prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.4 |
0.7 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.4 |
1.1 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.4 |
2.5 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.4 |
2.1 |
GO:0010884 |
positive regulation of lipid storage(GO:0010884) |
| 0.4 |
0.4 |
GO:0032692 |
negative regulation of interleukin-1 production(GO:0032692) |
| 0.4 |
0.4 |
GO:0002309 |
T cell proliferation involved in immune response(GO:0002309) |
| 0.4 |
0.7 |
GO:1902306 |
negative regulation of sodium ion transmembrane transport(GO:1902306) |
| 0.4 |
1.8 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.4 |
0.4 |
GO:0035751 |
regulation of lysosomal lumen pH(GO:0035751) |
| 0.4 |
0.4 |
GO:0032272 |
negative regulation of protein polymerization(GO:0032272) |
| 0.4 |
1.8 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.3 |
1.0 |
GO:0097178 |
ruffle assembly(GO:0097178) |
| 0.3 |
1.7 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.3 |
2.8 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.3 |
5.2 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.3 |
0.3 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.3 |
0.3 |
GO:0002901 |
mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.3 |
1.0 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.3 |
1.0 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.3 |
1.4 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.3 |
1.4 |
GO:0098743 |
cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
| 0.3 |
1.0 |
GO:0042097 |
interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.3 |
4.8 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.3 |
3.8 |
GO:0002931 |
response to ischemia(GO:0002931) |
| 0.3 |
4.8 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.3 |
0.3 |
GO:0060347 |
heart trabecula formation(GO:0060347) |
| 0.3 |
1.4 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.3 |
1.0 |
GO:0031069 |
hair follicle morphogenesis(GO:0031069) |
| 0.3 |
1.0 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.3 |
19.9 |
GO:0042273 |
ribosomal large subunit biogenesis(GO:0042273) |
| 0.3 |
1.0 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.3 |
11.1 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.3 |
2.4 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.3 |
1.7 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.3 |
0.7 |
GO:0048539 |
bone marrow development(GO:0048539) |
| 0.3 |
1.0 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.3 |
3.3 |
GO:0035414 |
negative regulation of catenin import into nucleus(GO:0035414) |
| 0.3 |
0.7 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.3 |
4.0 |
GO:0035640 |
exploration behavior(GO:0035640) |
| 0.3 |
5.0 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
| 0.3 |
2.0 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.3 |
1.3 |
GO:1905098 |
negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.3 |
0.7 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.3 |
0.7 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.3 |
0.7 |
GO:0015938 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 0.3 |
0.7 |
GO:0002922 |
positive regulation of humoral immune response(GO:0002922) |
| 0.3 |
1.6 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.3 |
3.3 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.3 |
1.0 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.3 |
1.0 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.3 |
0.7 |
GO:0061724 |
lipophagy(GO:0061724) |
| 0.3 |
1.0 |
GO:0030252 |
growth hormone secretion(GO:0030252) |
| 0.3 |
1.6 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.3 |
1.3 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.3 |
1.0 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.3 |
13.0 |
GO:0006414 |
translational elongation(GO:0006414) |
| 0.3 |
3.9 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.3 |
2.3 |
GO:0051014 |
actin filament severing(GO:0051014) |
| 0.3 |
0.3 |
GO:0010899 |
regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 0.3 |
1.0 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.3 |
3.2 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.3 |
1.9 |
GO:0032094 |
response to food(GO:0032094) |
| 0.3 |
0.3 |
GO:2001135 |
regulation of endocytic recycling(GO:2001135) |
| 0.3 |
0.3 |
GO:0090335 |
regulation of brown fat cell differentiation(GO:0090335) |
| 0.3 |
0.6 |
GO:0009838 |
abscission(GO:0009838) |
| 0.3 |
0.6 |
GO:2000778 |
positive regulation of interleukin-6 secretion(GO:2000778) |
| 0.3 |
1.3 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.3 |
0.6 |
GO:0039702 |
viral budding via host ESCRT complex(GO:0039702) |
| 0.3 |
0.3 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.3 |
2.2 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.3 |
2.8 |
GO:0006047 |
UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.3 |
1.2 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.3 |
7.1 |
GO:0006626 |
protein targeting to mitochondrion(GO:0006626) |
| 0.3 |
1.2 |
GO:0043987 |
histone H3-S10 phosphorylation(GO:0043987) |
| 0.3 |
0.3 |
GO:2000347 |
positive regulation of hepatocyte proliferation(GO:2000347) |
| 0.3 |
1.9 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.3 |
0.9 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.3 |
1.2 |
GO:0006534 |
cysteine metabolic process(GO:0006534) |
| 0.3 |
0.3 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.3 |
0.6 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.3 |
1.2 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.3 |
0.3 |
GO:0045601 |
regulation of endothelial cell differentiation(GO:0045601) |
| 0.3 |
0.6 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.3 |
0.6 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.3 |
0.6 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.3 |
1.2 |
GO:0071295 |
cellular response to vitamin(GO:0071295) |
| 0.3 |
0.9 |
GO:0038203 |
TORC2 signaling(GO:0038203) |
| 0.3 |
3.0 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.3 |
4.2 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.3 |
1.5 |
GO:0032008 |
positive regulation of TOR signaling(GO:0032008) |
| 0.3 |
1.8 |
GO:0043633 |
polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
| 0.3 |
0.3 |
GO:0009268 |
response to pH(GO:0009268) |
| 0.3 |
2.4 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
| 0.3 |
0.3 |
GO:0014834 |
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
| 0.3 |
0.3 |
GO:1903546 |
protein localization to photoreceptor outer segment(GO:1903546) |
| 0.3 |
2.1 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.3 |
1.2 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.3 |
0.9 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.3 |
2.6 |
GO:0097066 |
response to thyroid hormone(GO:0097066) |
| 0.3 |
2.9 |
GO:0009143 |
nucleoside triphosphate catabolic process(GO:0009143) |
| 0.3 |
1.2 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.3 |
0.9 |
GO:1904424 |
regulation of GTP binding(GO:1904424) |
| 0.3 |
1.2 |
GO:0015844 |
monoamine transport(GO:0015844) |
| 0.3 |
2.0 |
GO:1902416 |
positive regulation of mRNA binding(GO:1902416) positive regulation of RNA binding(GO:1905216) |
| 0.3 |
1.1 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.3 |
0.3 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.3 |
0.6 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.3 |
1.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.3 |
1.4 |
GO:0015858 |
nucleoside transport(GO:0015858) |
| 0.3 |
4.0 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.3 |
0.9 |
GO:1903977 |
positive regulation of Schwann cell migration(GO:1900149) positive regulation of glial cell migration(GO:1903977) |
| 0.3 |
4.0 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.3 |
1.1 |
GO:0019471 |
4-hydroxyproline metabolic process(GO:0019471) |
| 0.3 |
0.3 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.3 |
0.8 |
GO:2000254 |
regulation of male germ cell proliferation(GO:2000254) |
| 0.3 |
0.3 |
GO:0032464 |
regulation of protein homooligomerization(GO:0032462) positive regulation of protein homooligomerization(GO:0032464) |
| 0.3 |
1.1 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.3 |
1.4 |
GO:0043117 |
positive regulation of vascular permeability(GO:0043117) |
| 0.3 |
5.3 |
GO:0043949 |
regulation of cAMP-mediated signaling(GO:0043949) |
| 0.3 |
1.7 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.3 |
1.1 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.3 |
0.3 |
GO:2000138 |
positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.3 |
0.6 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.3 |
1.4 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.3 |
0.3 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.3 |
1.1 |
GO:0010543 |
regulation of platelet activation(GO:0010543) |
| 0.3 |
0.6 |
GO:0042401 |
amine biosynthetic process(GO:0009309) cellular biogenic amine biosynthetic process(GO:0042401) |
| 0.3 |
21.1 |
GO:1903749 |
positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
| 0.3 |
0.6 |
GO:0033280 |
response to vitamin D(GO:0033280) |
| 0.3 |
7.8 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.3 |
1.9 |
GO:0015697 |
quaternary ammonium group transport(GO:0015697) |
| 0.3 |
0.8 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.3 |
24.6 |
GO:0098792 |
xenophagy(GO:0098792) |
| 0.3 |
1.1 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.3 |
0.6 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.3 |
0.8 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.3 |
0.8 |
GO:0010656 |
negative regulation of muscle cell apoptotic process(GO:0010656) |
| 0.3 |
0.8 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.3 |
1.1 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.3 |
1.6 |
GO:0042168 |
heme metabolic process(GO:0042168) |
| 0.3 |
1.1 |
GO:1902931 |
negative regulation of alcohol biosynthetic process(GO:1902931) |
| 0.3 |
0.8 |
GO:0010950 |
positive regulation of endopeptidase activity(GO:0010950) positive regulation of peptidase activity(GO:0010952) |
| 0.3 |
1.9 |
GO:1901162 |
serotonin biosynthetic process(GO:0042427) indole-containing compound biosynthetic process(GO:0042435) primary amino compound biosynthetic process(GO:1901162) |
| 0.3 |
2.4 |
GO:0097484 |
dendrite extension(GO:0097484) |
| 0.3 |
3.2 |
GO:0006743 |
ubiquinone metabolic process(GO:0006743) |
| 0.3 |
1.9 |
GO:0042346 |
positive regulation of NF-kappaB import into nucleus(GO:0042346) |
| 0.3 |
0.3 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.3 |
1.9 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.3 |
4.2 |
GO:0045744 |
negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.3 |
0.8 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.3 |
7.4 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.3 |
0.3 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.3 |
1.8 |
GO:0006119 |
oxidative phosphorylation(GO:0006119) |
| 0.3 |
3.4 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.3 |
1.0 |
GO:0030423 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.3 |
0.3 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.3 |
0.3 |
GO:0032785 |
negative regulation of DNA-templated transcription, elongation(GO:0032785) |
| 0.3 |
0.5 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.3 |
0.3 |
GO:0019087 |
transformation of host cell by virus(GO:0019087) |
| 0.3 |
0.8 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.3 |
2.6 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.3 |
1.0 |
GO:0033299 |
secretion of lysosomal enzymes(GO:0033299) |
| 0.3 |
0.3 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.3 |
0.8 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.3 |
0.5 |
GO:0016137 |
glycoside metabolic process(GO:0016137) |
| 0.3 |
0.3 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.3 |
0.3 |
GO:0016559 |
peroxisome fission(GO:0016559) |
| 0.3 |
1.0 |
GO:0065005 |
protein-lipid complex assembly(GO:0065005) |
| 0.3 |
0.5 |
GO:0045578 |
negative regulation of B cell differentiation(GO:0045578) |
| 0.3 |
0.3 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.3 |
11.3 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.3 |
0.5 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.3 |
0.5 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
| 0.2 |
0.2 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.2 |
1.2 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.2 |
0.7 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.2 |
1.5 |
GO:0006144 |
purine nucleobase metabolic process(GO:0006144) |
| 0.2 |
0.5 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.2 |
0.5 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 0.2 |
2.2 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.2 |
1.9 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.2 |
1.4 |
GO:0031295 |
lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.2 |
1.0 |
GO:0021756 |
striatum development(GO:0021756) |
| 0.2 |
0.7 |
GO:0033108 |
mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.2 |
1.7 |
GO:0032715 |
negative regulation of interleukin-6 production(GO:0032715) |
| 0.2 |
0.7 |
GO:0071398 |
cellular response to fatty acid(GO:0071398) |
| 0.2 |
0.5 |
GO:0050779 |
RNA destabilization(GO:0050779) |
| 0.2 |
1.4 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.2 |
0.5 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.2 |
0.5 |
GO:0060431 |
primary lung bud formation(GO:0060431) |
| 0.2 |
1.2 |
GO:0060528 |
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.2 |
0.7 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.2 |
0.2 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.2 |
2.4 |
GO:0071548 |
response to dexamethasone(GO:0071548) |
| 0.2 |
0.5 |
GO:1901724 |
positive regulation of cell proliferation involved in kidney development(GO:1901724) |
| 0.2 |
0.7 |
GO:2000194 |
regulation of female gonad development(GO:2000194) |
| 0.2 |
0.9 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.2 |
3.3 |
GO:0043153 |
entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.2 |
0.7 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.2 |
0.7 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.2 |
1.2 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.2 |
0.5 |
GO:0061181 |
regulation of chondrocyte development(GO:0061181) |
| 0.2 |
0.9 |
GO:0006684 |
sphingomyelin metabolic process(GO:0006684) |
| 0.2 |
1.2 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.2 |
0.2 |
GO:0046036 |
CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) |
| 0.2 |
1.2 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.2 |
0.2 |
GO:0044851 |
anagen(GO:0042640) hair cycle phase(GO:0044851) |
| 0.2 |
0.5 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.2 |
11.0 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.2 |
0.9 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.2 |
0.2 |
GO:1900272 |
negative regulation of long-term synaptic potentiation(GO:1900272) |
| 0.2 |
2.9 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
| 0.2 |
5.9 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.2 |
4.3 |
GO:0030199 |
collagen fibril organization(GO:0030199) |
| 0.2 |
4.2 |
GO:0006165 |
nucleoside diphosphate phosphorylation(GO:0006165) |
| 0.2 |
4.9 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.2 |
1.8 |
GO:0009142 |
nucleoside triphosphate biosynthetic process(GO:0009142) |
| 0.2 |
0.9 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.2 |
0.2 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.2 |
1.8 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.2 |
0.4 |
GO:0086045 |
membrane depolarization during AV node cell action potential(GO:0086045) |
| 0.2 |
0.7 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.2 |
0.7 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.2 |
1.1 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.2 |
0.4 |
GO:0034969 |
histone arginine methylation(GO:0034969) |
| 0.2 |
0.4 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.2 |
0.2 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.2 |
5.0 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.2 |
0.9 |
GO:0035993 |
deltoid tuberosity development(GO:0035993) |
| 0.2 |
0.9 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.2 |
2.6 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.2 |
0.4 |
GO:0002526 |
acute inflammatory response(GO:0002526) |
| 0.2 |
1.3 |
GO:0001921 |
positive regulation of receptor recycling(GO:0001921) |
| 0.2 |
0.2 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.2 |
0.2 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.2 |
0.2 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.2 |
10.2 |
GO:1901379 |
regulation of potassium ion transmembrane transport(GO:1901379) |
| 0.2 |
2.8 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.2 |
1.1 |
GO:0042160 |
plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 0.2 |
1.1 |
GO:0033089 |
positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.2 |
6.2 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
| 0.2 |
1.5 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.2 |
0.4 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 |
0.6 |
GO:0002693 |
positive regulation of cellular extravasation(GO:0002693) |
| 0.2 |
0.6 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.2 |
0.2 |
GO:0035701 |
hematopoietic stem cell migration(GO:0035701) |
| 0.2 |
0.8 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.2 |
0.8 |
GO:0042993 |
positive regulation of transcription factor import into nucleus(GO:0042993) |
| 0.2 |
1.3 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 0.2 |
0.2 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.2 |
0.6 |
GO:1904742 |
regulation of telomeric DNA binding(GO:1904742) |
| 0.2 |
1.0 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.2 |
0.2 |
GO:0045932 |
negative regulation of muscle contraction(GO:0045932) |
| 0.2 |
2.2 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.2 |
0.4 |
GO:0009193 |
pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine ribonucleoside diphosphate metabolic process(GO:0009193) UDP metabolic process(GO:0046048) |
| 0.2 |
0.4 |
GO:0046470 |
phosphatidylcholine metabolic process(GO:0046470) |
| 0.2 |
0.6 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.2 |
0.2 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.2 |
0.6 |
GO:1901030 |
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.2 |
0.8 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.2 |
3.0 |
GO:0045471 |
response to ethanol(GO:0045471) |
| 0.2 |
0.2 |
GO:0070849 |
response to epidermal growth factor(GO:0070849) |
| 0.2 |
2.8 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.2 |
0.6 |
GO:1902396 |
positive regulation of pinocytosis(GO:0048549) protein localization to bicellular tight junction(GO:1902396) |
| 0.2 |
0.6 |
GO:1902176 |
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902176) |
| 0.2 |
0.6 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.2 |
0.4 |
GO:0050710 |
negative regulation of cytokine secretion(GO:0050710) |
| 0.2 |
0.4 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.2 |
2.0 |
GO:0051898 |
negative regulation of protein kinase B signaling(GO:0051898) |
| 0.2 |
0.6 |
GO:0097309 |
cap1 mRNA methylation(GO:0097309) |
| 0.2 |
0.8 |
GO:0031509 |
telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 0.2 |
0.8 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.2 |
1.2 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.2 |
1.9 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.2 |
0.2 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.2 |
1.0 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.2 |
1.9 |
GO:0045103 |
intermediate filament-based process(GO:0045103) |
| 0.2 |
0.2 |
GO:0060279 |
regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.2 |
0.4 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.2 |
0.6 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.2 |
2.9 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.2 |
0.2 |
GO:0006778 |
porphyrin-containing compound metabolic process(GO:0006778) |
| 0.2 |
2.3 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.2 |
1.0 |
GO:0048715 |
negative regulation of oligodendrocyte differentiation(GO:0048715) |
| 0.2 |
0.2 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) |
| 0.2 |
4.6 |
GO:0050728 |
negative regulation of inflammatory response(GO:0050728) |
| 0.2 |
3.6 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.2 |
0.6 |
GO:0071105 |
response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
| 0.2 |
6.9 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.2 |
0.9 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.2 |
0.4 |
GO:0060046 |
regulation of acrosome reaction(GO:0060046) |
| 0.2 |
0.6 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.2 |
3.3 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.2 |
0.4 |
GO:0003245 |
growth involved in heart morphogenesis(GO:0003241) cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.2 |
0.7 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.2 |
0.9 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.2 |
0.6 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.2 |
0.2 |
GO:0033206 |
meiotic cytokinesis(GO:0033206) |
| 0.2 |
0.4 |
GO:0051491 |
positive regulation of filopodium assembly(GO:0051491) |
| 0.2 |
0.7 |
GO:0060312 |
regulation of blood vessel remodeling(GO:0060312) |
| 0.2 |
7.0 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.2 |
1.1 |
GO:0051958 |
methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 0.2 |
0.4 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
| 0.2 |
1.4 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.2 |
0.2 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.2 |
0.4 |
GO:0044068 |
modulation by symbiont of host cellular process(GO:0044068) |
| 0.2 |
2.6 |
GO:0097345 |
mitochondrial outer membrane permeabilization(GO:0097345) |
| 0.2 |
0.3 |
GO:0003418 |
growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.2 |
1.0 |
GO:0046031 |
purine nucleoside diphosphate metabolic process(GO:0009135) purine ribonucleoside diphosphate metabolic process(GO:0009179) ADP metabolic process(GO:0046031) |
| 0.2 |
3.9 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.2 |
0.3 |
GO:0046104 |
thymidine metabolic process(GO:0046104) |
| 0.2 |
0.3 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.2 |
0.3 |
GO:0002367 |
cytokine production involved in immune response(GO:0002367) |
| 0.2 |
0.5 |
GO:0045324 |
late endosome to vacuole transport(GO:0045324) |
| 0.2 |
1.0 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.2 |
0.2 |
GO:0008054 |
negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
| 0.2 |
0.2 |
GO:0072602 |
interleukin-4 secretion(GO:0072602) |
| 0.2 |
1.7 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.2 |
0.2 |
GO:0010039 |
response to iron ion(GO:0010039) |
| 0.2 |
0.5 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.2 |
0.2 |
GO:0071674 |
mononuclear cell migration(GO:0071674) |
| 0.2 |
0.8 |
GO:0090502 |
RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
| 0.2 |
1.0 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.2 |
0.8 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.2 |
0.2 |
GO:0032070 |
regulation of deoxyribonuclease activity(GO:0032070) |
| 0.2 |
0.5 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.2 |
0.8 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.2 |
1.8 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.2 |
2.1 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.2 |
0.2 |
GO:0046070 |
dGTP metabolic process(GO:0046070) purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.2 |
0.3 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.2 |
0.3 |
GO:0009649 |
entrainment of circadian clock(GO:0009649) |
| 0.2 |
0.3 |
GO:0015012 |
heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.2 |
2.0 |
GO:0006818 |
hydrogen transport(GO:0006818) |
| 0.2 |
0.3 |
GO:0033690 |
positive regulation of osteoblast proliferation(GO:0033690) |
| 0.2 |
2.0 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.2 |
0.5 |
GO:0036481 |
intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 0.2 |
0.3 |
GO:0048636 |
positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
| 0.2 |
1.1 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.2 |
0.6 |
GO:0007635 |
chemosensory behavior(GO:0007635) olfactory behavior(GO:0042048) |
| 0.2 |
0.5 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.2 |
0.3 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.2 |
0.8 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.2 |
5.5 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.2 |
0.2 |
GO:0061365 |
positive regulation of triglyceride lipase activity(GO:0061365) |
| 0.2 |
0.8 |
GO:0003417 |
growth plate cartilage development(GO:0003417) |
| 0.2 |
1.4 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.2 |
0.2 |
GO:0044849 |
estrous cycle(GO:0044849) |
| 0.2 |
0.2 |
GO:1902177 |
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.2 |
0.3 |
GO:0009138 |
pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
| 0.2 |
0.5 |
GO:0014829 |
vascular smooth muscle contraction(GO:0014829) |
| 0.1 |
0.4 |
GO:0050812 |
regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.1 |
4.1 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.1 |
0.3 |
GO:1904181 |
positive regulation of membrane depolarization(GO:1904181) |
| 0.1 |
0.1 |
GO:0010815 |
bradykinin catabolic process(GO:0010815) |
| 0.1 |
0.7 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 |
0.1 |
GO:0090312 |
positive regulation of protein deacetylation(GO:0090312) |
| 0.1 |
0.3 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.1 |
1.4 |
GO:0006879 |
cellular iron ion homeostasis(GO:0006879) |
| 0.1 |
0.7 |
GO:0009301 |
snRNA transcription(GO:0009301) |
| 0.1 |
1.0 |
GO:1901223 |
negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
| 0.1 |
0.3 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.1 |
1.4 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
0.1 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.1 |
3.9 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.1 |
0.3 |
GO:0043144 |
snoRNA processing(GO:0043144) |
| 0.1 |
1.3 |
GO:0006362 |
transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.1 |
0.3 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.1 |
0.6 |
GO:0019509 |
L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 |
0.3 |
GO:0042447 |
hormone catabolic process(GO:0042447) |
| 0.1 |
0.4 |
GO:0045950 |
negative regulation of mitotic recombination(GO:0045950) |
| 0.1 |
1.4 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.1 |
1.1 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 |
0.9 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 |
1.3 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.1 |
2.3 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.1 |
0.3 |
GO:1900452 |
regulation of long term synaptic depression(GO:1900452) |
| 0.1 |
0.3 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.1 |
0.1 |
GO:0044827 |
modulation by host of viral genome replication(GO:0044827) |
| 0.1 |
0.4 |
GO:0007183 |
SMAD protein complex assembly(GO:0007183) |
| 0.1 |
0.1 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.1 |
0.5 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.1 |
1.6 |
GO:0097576 |
autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
| 0.1 |
0.5 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
| 0.1 |
0.4 |
GO:2000758 |
positive regulation of histone acetylation(GO:0035066) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
| 0.1 |
0.5 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.1 |
0.5 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.1 |
0.3 |
GO:2000157 |
regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.1 |
0.4 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
0.5 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.1 |
3.3 |
GO:0021680 |
cerebellar Purkinje cell layer development(GO:0021680) |
| 0.1 |
0.1 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.1 |
0.1 |
GO:0001961 |
positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
| 0.1 |
0.3 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.1 |
0.4 |
GO:0072337 |
modified amino acid transport(GO:0072337) |
| 0.1 |
0.5 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 |
1.3 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.1 |
0.4 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 |
2.0 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.1 |
0.2 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 0.1 |
0.4 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.1 |
0.9 |
GO:0033683 |
nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.1 |
2.1 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.1 |
0.1 |
GO:0001777 |
T cell homeostatic proliferation(GO:0001777) |
| 0.1 |
0.8 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.1 |
0.5 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 |
0.9 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 |
0.6 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 |
0.4 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
0.4 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.1 |
0.1 |
GO:0044320 |
leptin-mediated signaling pathway(GO:0033210) cellular response to leptin stimulus(GO:0044320) |
| 0.1 |
0.2 |
GO:0060830 |
ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.1 |
0.2 |
GO:0045349 |
interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
| 0.1 |
0.1 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.1 |
0.3 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 |
0.6 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.1 |
0.2 |
GO:0051923 |
sulfation(GO:0051923) |
| 0.1 |
0.2 |
GO:0043516 |
regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) |
| 0.1 |
1.2 |
GO:0002053 |
positive regulation of mesenchymal cell proliferation(GO:0002053) |
| 0.1 |
1.9 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.1 |
0.7 |
GO:0098751 |
bone cell development(GO:0098751) |
| 0.1 |
0.2 |
GO:0015675 |
nickel cation transport(GO:0015675) |
| 0.1 |
0.3 |
GO:0046460 |
neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.1 |
1.3 |
GO:0006509 |
membrane protein ectodomain proteolysis(GO:0006509) |
| 0.1 |
0.4 |
GO:0007200 |
phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.1 |
0.1 |
GO:0048262 |
determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
| 0.1 |
0.2 |
GO:0045684 |
positive regulation of epidermis development(GO:0045684) |
| 0.1 |
0.4 |
GO:0046909 |
intermembrane transport(GO:0046909) |
| 0.1 |
0.5 |
GO:0021535 |
cell migration in hindbrain(GO:0021535) |
| 0.1 |
0.2 |
GO:0070092 |
glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 0.1 |
1.6 |
GO:0001553 |
luteinization(GO:0001553) |
| 0.1 |
0.6 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
0.3 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.1 |
0.2 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.1 |
0.2 |
GO:0035552 |
oxidative RNA demethylation(GO:0035513) oxidative single-stranded DNA demethylation(GO:0035552) oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.1 |
0.7 |
GO:0035646 |
endosome to melanosome transport(GO:0035646) pigment accumulation(GO:0043476) cellular pigment accumulation(GO:0043482) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.1 |
0.2 |
GO:0050729 |
positive regulation of inflammatory response(GO:0050729) |
| 0.1 |
0.2 |
GO:0070989 |
oxidative demethylation(GO:0070989) |
| 0.1 |
0.5 |
GO:0045123 |
cellular extravasation(GO:0045123) |
| 0.1 |
0.3 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.1 |
0.2 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.1 |
0.1 |
GO:0002331 |
pre-B cell allelic exclusion(GO:0002331) |
| 0.1 |
1.0 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.1 |
3.3 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.1 |
0.2 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 |
0.8 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.1 |
0.6 |
GO:1903352 |
ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 0.1 |
0.3 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.1 |
0.4 |
GO:0032401 |
establishment of melanosome localization(GO:0032401) establishment of pigment granule localization(GO:0051905) |
| 0.1 |
0.2 |
GO:0009148 |
pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) |
| 0.1 |
0.2 |
GO:0046133 |
pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.1 |
0.3 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.1 |
0.5 |
GO:0002093 |
auditory receptor cell morphogenesis(GO:0002093) |
| 0.1 |
0.3 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.1 |
0.6 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
0.1 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 0.1 |
0.3 |
GO:0090181 |
regulation of cholesterol metabolic process(GO:0090181) |
| 0.1 |
0.2 |
GO:0006972 |
hyperosmotic response(GO:0006972) |
| 0.1 |
0.1 |
GO:0072044 |
collecting duct development(GO:0072044) |
| 0.1 |
0.3 |
GO:0051084 |
'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
| 0.1 |
0.1 |
GO:0032240 |
negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
| 0.1 |
0.3 |
GO:0002176 |
male germ cell proliferation(GO:0002176) |
| 0.1 |
0.3 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.1 |
0.5 |
GO:0044387 |
negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.1 |
0.2 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.1 |
1.8 |
GO:0098661 |
inorganic anion transmembrane transport(GO:0098661) |
| 0.1 |
0.7 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.1 |
0.2 |
GO:0046719 |
regulation by virus of viral protein levels in host cell(GO:0046719) |
| 0.1 |
0.1 |
GO:0034113 |
heterotypic cell-cell adhesion(GO:0034113) |
| 0.1 |
1.1 |
GO:0045761 |
regulation of adenylate cyclase activity(GO:0045761) |
| 0.1 |
0.1 |
GO:0030046 |
parallel actin filament bundle assembly(GO:0030046) |
| 0.1 |
1.1 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.1 |
0.1 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.1 |
0.2 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.1 |
0.3 |
GO:0046685 |
response to arsenic-containing substance(GO:0046685) |
| 0.1 |
0.1 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.1 |
0.3 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.1 |
2.7 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.1 |
0.1 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.1 |
0.1 |
GO:1901798 |
positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.1 |
0.1 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.1 |
0.4 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.1 |
0.1 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 |
0.7 |
GO:0055072 |
iron ion homeostasis(GO:0055072) |
| 0.1 |
0.4 |
GO:0010765 |
positive regulation of sodium ion transport(GO:0010765) |
| 0.1 |
3.1 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.1 |
0.1 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.1 |
0.2 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.1 |
0.1 |
GO:0032687 |
negative regulation of interferon-alpha production(GO:0032687) |
| 0.1 |
0.8 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.1 |
0.1 |
GO:0015817 |
histidine transport(GO:0015817) |
| 0.1 |
1.5 |
GO:0006821 |
chloride transport(GO:0006821) |
| 0.1 |
0.1 |
GO:0071440 |
regulation of histone H3-K14 acetylation(GO:0071440) |
| 0.1 |
0.3 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.1 |
0.3 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.1 |
0.4 |
GO:1990564 |
protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 |
0.1 |
GO:0045661 |
regulation of myoblast differentiation(GO:0045661) |
| 0.1 |
0.3 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.1 |
0.1 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.1 |
0.2 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.1 |
0.2 |
GO:0010804 |
negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
| 0.1 |
0.1 |
GO:0045346 |
regulation of MHC class II biosynthetic process(GO:0045346) negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 |
0.3 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.1 |
0.2 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.1 |
1.3 |
GO:0008637 |
apoptotic mitochondrial changes(GO:0008637) |
| 0.1 |
0.2 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
0.8 |
GO:0042158 |
lipoprotein biosynthetic process(GO:0042158) |
| 0.1 |
0.1 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.1 |
0.1 |
GO:0001828 |
inner cell mass cell differentiation(GO:0001826) inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
| 0.1 |
1.4 |
GO:0030168 |
platelet activation(GO:0030168) |
| 0.1 |
0.2 |
GO:0072102 |
glomerulus morphogenesis(GO:0072102) |
| 0.1 |
0.7 |
GO:0032355 |
response to estradiol(GO:0032355) |
| 0.1 |
0.1 |
GO:0071929 |
alpha-tubulin acetylation(GO:0071929) |
| 0.1 |
0.3 |
GO:0043518 |
negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.1 |
0.1 |
GO:0006839 |
mitochondrial transport(GO:0006839) |
| 0.1 |
0.8 |
GO:0046579 |
positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.1 |
0.1 |
GO:0070498 |
interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.1 |
0.3 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
0.1 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.1 |
0.4 |
GO:0043113 |
receptor clustering(GO:0043113) |
| 0.1 |
0.6 |
GO:0051092 |
positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
| 0.1 |
0.8 |
GO:1901343 |
negative regulation of vasculature development(GO:1901343) |
| 0.1 |
0.4 |
GO:0007006 |
mitochondrial membrane organization(GO:0007006) |
| 0.1 |
0.1 |
GO:0014010 |
Schwann cell proliferation(GO:0014010) |
| 0.0 |
0.4 |
GO:0006767 |
water-soluble vitamin metabolic process(GO:0006767) |
| 0.0 |
0.1 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.0 |
0.7 |
GO:0099531 |
presynaptic process involved in chemical synaptic transmission(GO:0099531) |
| 0.0 |
0.2 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.0 |
0.7 |
GO:0072376 |
protein activation cascade(GO:0072376) |
| 0.0 |
0.1 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.0 |
0.2 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 0.0 |
0.2 |
GO:0021670 |
lateral ventricle development(GO:0021670) |
| 0.0 |
0.4 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.0 |
0.6 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.0 |
0.1 |
GO:0009256 |
10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.0 |
0.1 |
GO:0044406 |
adhesion of symbiont to host(GO:0044406) |
| 0.0 |
0.3 |
GO:2000009 |
negative regulation of protein localization to cell surface(GO:2000009) |
| 0.0 |
0.1 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.0 |
0.0 |
GO:0021555 |
midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.0 |
0.1 |
GO:0051560 |
mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.0 |
0.4 |
GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
| 0.0 |
0.5 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
0.0 |
GO:0021562 |
vestibulocochlear nerve development(GO:0021562) |
| 0.0 |
0.1 |
GO:0033865 |
nucleoside bisphosphate metabolic process(GO:0033865) ribonucleoside bisphosphate metabolic process(GO:0033875) purine nucleoside bisphosphate metabolic process(GO:0034032) |
| 0.0 |
0.2 |
GO:0034142 |
toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.0 |
0.1 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.0 |
0.1 |
GO:0032693 |
negative regulation of interleukin-10 production(GO:0032693) |
| 0.0 |
0.1 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.0 |
0.3 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.0 |
0.1 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 |
0.1 |
GO:0051148 |
negative regulation of muscle cell differentiation(GO:0051148) |
| 0.0 |
0.6 |
GO:0016079 |
synaptic vesicle exocytosis(GO:0016079) |
| 0.0 |
0.2 |
GO:0021678 |
third ventricle development(GO:0021678) |
| 0.0 |
0.1 |
GO:0070555 |
response to interleukin-1(GO:0070555) |
| 0.0 |
0.1 |
GO:0031343 |
positive regulation of cell killing(GO:0031343) |
| 0.0 |
0.5 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 |
0.1 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.0 |
0.3 |
GO:0046174 |
polyol catabolic process(GO:0046174) |
| 0.0 |
0.2 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.0 |
0.2 |
GO:0006896 |
Golgi to vacuole transport(GO:0006896) |
| 0.0 |
0.1 |
GO:0050849 |
negative regulation of calcium-mediated signaling(GO:0050849) |
| 0.0 |
0.0 |
GO:0032490 |
detection of molecule of bacterial origin(GO:0032490) |
| 0.0 |
0.1 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.0 |
0.1 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.0 |
0.1 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.0 |
0.0 |
GO:0046477 |
glycosylceramide catabolic process(GO:0046477) |
| 0.0 |
0.2 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.0 |
0.1 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.0 |
0.1 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.0 |
0.1 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.0 |
0.1 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.0 |
0.2 |
GO:0009988 |
cell-cell recognition(GO:0009988) |
| 0.0 |
0.0 |
GO:0038166 |
angiotensin-activated signaling pathway(GO:0038166) |
| 0.0 |
0.1 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.0 |
0.1 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.0 |
0.0 |
GO:2001223 |
negative regulation of neuron migration(GO:2001223) |
| 0.0 |
0.0 |
GO:0031670 |
cellular response to nutrient(GO:0031670) |
| 0.0 |
0.4 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.7 |
GO:0006446 |
regulation of translational initiation(GO:0006446) |
| 0.0 |
0.0 |
GO:0021794 |
thalamus development(GO:0021794) |
| 0.0 |
0.0 |
GO:0006625 |
protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.0 |
0.1 |
GO:0052695 |
cellular glucuronidation(GO:0052695) |
| 0.0 |
0.2 |
GO:0010324 |
membrane invagination(GO:0010324) |
| 0.0 |
0.2 |
GO:0034765 |
regulation of ion transmembrane transport(GO:0034765) |
| 0.0 |
0.1 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.1 |
GO:0042219 |
cellular modified amino acid catabolic process(GO:0042219) |
| 0.0 |
0.1 |
GO:0036035 |
osteoclast development(GO:0036035) |
| 0.0 |
0.0 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 |
0.1 |
GO:0010747 |
positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
| 0.0 |
0.1 |
GO:0034472 |
snRNA 3'-end processing(GO:0034472) |
| 0.0 |
0.0 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.0 |
0.1 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.0 |
0.5 |
GO:0016125 |
sterol metabolic process(GO:0016125) |
| 0.0 |
0.1 |
GO:0044110 |
growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
| 0.0 |
0.1 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.0 |
0.1 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.0 |
0.0 |
GO:1900015 |
regulation of cytokine production involved in inflammatory response(GO:1900015) |
| 0.0 |
0.3 |
GO:0098780 |
mitophagy in response to mitochondrial depolarization(GO:0098779) response to mitochondrial depolarisation(GO:0098780) |
| 0.0 |
1.1 |
GO:0008654 |
phospholipid biosynthetic process(GO:0008654) |
| 0.0 |
0.0 |
GO:1990253 |
cellular response to leucine starvation(GO:1990253) |
| 0.0 |
0.0 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.0 |
0.0 |
GO:0000054 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
| 0.0 |
0.0 |
GO:0046931 |
pore complex assembly(GO:0046931) |
| 0.0 |
0.1 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.0 |
0.0 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
